Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Gamma Knife Market Outlook from 2023 to 2033

The gamma knife market size is projected to be worth US$ 337.7 million in 2023. The market is likely to reach US$ 702.5 million by 2033. The market is further expected to surge at a CAGR of 7.6% during the forecast period 2023 to 2033.

Key Market Trends and Highlights

  • Favorable reimbursement policies in some regions are making gamma knife treatment more accessible to patients, thereby increasing its adoption.
  • Initially used primarily for the treatment of brain tumors, gamma knife is now being applied to other conditions, including arteriovenous malformations (AVMs), trigeminal neuralgia, and epilepsy. The expansion of applications is expected to drive market growth.
  • Emerging economies, particularly in Asia and Latin America, are witnessing an increase in healthcare infrastructure development, which offers new growth opportunities for gamma knife technology providers.
  • Manufacturers of gamma knife systems are forming partnerships with healthcare institutions to promote the technology, educate medical professionals, and enhance its accessibility.
Attributes Key Insights
Gamma Knife Market Estimated Size in 2023 US$ 337.7 million
Projected Market Value in 2033 US$ 702.5 million
Value-based CAGR from 2023 to 2033 7.6%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2018 to 2022 Historical Analysis vs. 2023 to 2033 Market Forecast Projections

The scope for gamma knife rose at a 7.2% CAGR between 2018 and 2022. The global market for gamma knife is anticipated to grow at a moderate CAGR of 7.6% over the forecast period 2023 to 2033.

Report Attributes Details
Market Value in 2018 US$ 237.6 million
Market Value in 2022 US$ 313.8 million
CAGR from 2018 to 2022 7.2%

During the historical period 2018 to 2022, the gamma knife market experienced steady growth. Factors such as the increasing prevalence of brain tumors, neurological disorders, and cancer related conditions contributed to the demand for precise and non invasive treatment options.

The gamma knife technology saw continuous advancements in imaging, dose planning, and automation. The improvements enhanced the precision and effectiveness of the procedure, making it a preferred choice for many healthcare providers and patients.

Patients and healthcare providers increasingly favored minimally invasive procedures to reduce risks, complications, and recovery times. Gamma knife offered a non invasive alternative for various neurosurgical treatments.

Looking ahead to the period from 2023 to 2033, several key trends and forecasted developments are expected to shape the gamma knife market. The factors that drove its historical growth are anticipated to persist and even strengthen.

The aging population and the increasing prevalence of cancer, especially in developing countries, will drive the demand for precise and minimally invasive cancer treatments. Brain metastasis and brain tumors are likely to be significant contributors to this growth.

The technology is expected to evolve further, with improved imaging, real time monitoring, and automated dose planning. The advancements will enhance the precision and safety of the procedure, making it an even more attractive treatment option.

Gamma Knife Market Key Drivers

  • The rising prevalence of brain tumors and various neurological conditions is a significant driver for the gamma knife market. Gamma knife radiosurgery offers a non invasive and precise treatment option for these conditions.
  • The incidence of age related neurological disorders like Parkinson's disease and essential tremors is on the rise, with the global aging population. Gamma knife is an attractive treatment option for elderly patients due to its non-invasive nature.
  • Continuous advancements in gamma knife technology have improved precision and treatment outcomes. The integration of image guided systems, automation, and real time monitoring has enhanced the overall efficacy and safety of the procedure.
  • Growing awareness among both healthcare providers and patients about the benefits of gamma knife radiosurgery is boosting its adoption. Patients are increasingly seeking minimally invasive treatment options.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Challenges in the Gamma Knife Market

  • Gamma knife systems are expensive to acquire and install. The high initial investment can deter some healthcare institutions from adopting this technology, especially in resource constrained settings.
  • In many regions, access to gamma knife centers is limited, and there may be a lack of awareness among healthcare providers and patients about the benefits of radiosurgery, leading to underutilization.
  • Alternative treatment options, including traditional surgery, chemotherapy, and other radiation therapies, may compete with gamma knife radiosurgery. The choice of treatment depends on the specific case and patient factors.
  • Obtaining regulatory approvals for gamma knife systems and expanding their indications can be a lengthy and complex process, delaying market entry and limiting applications.

Comparative View of Adjacent Industries

Future Market Insights has compared two other industries, mobile gamma camera market, and paint knife market below. The analysis showcases that gamma knife market is set to dominate out of these three industries over the forecast period 2023 to 2033.

Medical tourists seeking advanced treatments are drawn to gamma knife centers of excellence in different parts of the world, presenting an opportunity for market growth.

Gamma Knife Market:

CAGR from 2023 to 2033 7.6%
Market Value in 2033 US$ 702.5 million
Key Trends
  • The trend toward personalized medicine is increasing, and gamma knife radiosurgery can be tailored to specific condition of each patient, which aligns with the growing demand for individualized treatment approaches.
  • Patient preferences are shifting toward minimally invasive treatments, and gamma knife radiosurgery is a non invasive alternative to traditional surgical procedures, reducing the risks and recovery times.
Opportunity
  • The increase in healthcare spending in many countries, especially for advanced medical technologies, can support the adoption of gamma knife systems.
  • The ability of gamma knife to minimize side effects and complications becomes a significant selling point, as healthcare systems focus more on patient outcomes and quality of life.

Mobile Gamma Camera Market:

CAGR from 2023 to 2033 4.2%
Market Value in 2033 US$ 89.8 billion
Key Trends
  • The increasing prevalence of chronic diseases, including cancer, cardiovascular conditions, and orthopedic issues, is driving the demand for diagnostic imaging solutions. Mobile gamma cameras are versatile tools for various diagnostic applications.
  • Mobile gamma cameras offer flexibility in terms of deployment, allowing healthcare facilities to move the equipment to different locations within a hospital or between facilities, which is especially beneficial for addressing patient needs in different areas of a hospital.
Opportunity
  • Point-of-care diagnostics are gaining importance, and mobile gamma cameras are well suited for delivering diagnostic imaging directly at the bedside of patient, which reduces the need for patient transport and enhances efficiency.
  • Nuclear medicine procedures, which rely on gamma cameras, are increasingly being used for the diagnosis and treatment of various diseases, including cancer and cardiac conditions, which drives the demand for mobile gamma cameras.

Knife Sterilizer Market:

CAGR from 2023 to 2033 3.4%
Market Value in 2033 US$ 918.5 million
Key Trends
  • In the food service industry, ensuring food safety and hygiene is of paramount importance. Knife sterilizers help prevent cross contamination, ensuring that knives are safe to use, which is essential in commercial kitchens, restaurants, and food processing facilities.
  • Proper knife sterilization can significantly reduce the risk of foodborne illnesses caused by contaminated knives. The demand for knife sterilization equipment is on the rise, with growing awareness of food safety.
Opportunity
  • Health and safety regulations and guidelines in the food industry and healthcare sector require the use of sanitized and sterilized equipment. Compliance with these regulations is a key driver of the market.
  • In healthcare facilities, including hospitals and clinics, knife sterilizers are essential for the sterilization of surgical instruments, ensuring aseptic conditions during medical procedures.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-wise Insights

The below table showcases revenues in terms of the top 5 leading countries, spearheaded by India and China. Both countries are expected to lead the market through 2033.

Forecast CAGRs from 2023 to 2033

Germany 3.8%
Japan 7.1%
Australia 8.4%
China 9.9%
India 11.4%

Advanced Healthcare Infrastructure Driving the Market in Germany

The gamma knife market in Germany expected to expand at a CAGR of 3.8% through 2033.

Germany is experiencing a rise in the incidence of brain tumors, neurological disorders, and conditions such as trigeminal neuralgia. Gamma knife radiosurgery offers a precise, non invasive treatment option for these conditions.

Germany boasts a well developed healthcare infrastructure with access to cutting edge medical technologies. The country has several renowned medical centers that offer gamma knife services. Patients are increasingly seeking minimally invasive treatment options to reduce risks, complications, and recovery times. Gamma knife provides a non invasive alternative for neurosurgical procedures.

Continuous advancements in gamma knife technology, such as improved imaging, real time monitoring, and automation, enhance the precision and safety of the procedure, making it more appealing to both healthcare providers and patients.

Medical Tourism to Accelerate Market Growth in India

The gamma knife market in India is anticipated to expand at a CAGR of 11.4% through 2033.

India is a significant destination for medical tourism, attracting patients from around the world. Gamma knife centers of excellence in India can serve international patients, contributing to market growth. Government initiatives aimed at promoting advanced medical technologies and improving healthcare infrastructure can stimulate the adoption of Gamma Knife in India.

Continuous advancements in gamma knife technology, such as improved imaging, real time monitoring, and automation, enhance the precision and safety of the procedure, making it more appealing to both healthcare providers and patients.

Growing awareness among healthcare providers and patients about the benefits of gamma knife radiosurgery, as well as educational programs conducted by gamma knife centers, can contribute to its adoption.

Technological Advancements Fueling the Market in Japan

The gamma knife market in Japan is poised to expand at a CAGR of 7.1% through 2033.

Continuous advancements in gamma knife technology, such as improved imaging, real time monitoring, and automation, enhance the precision and safety of the procedure, making it more appealing to both healthcare providers and patients.

Collaboration between gamma knife technology providers and prominent healthcare institutions in Japan can promote advanced treatments and the technology itself, making it more accessible to patients.

Favorable reimbursement policies in Japan can make gamma knife treatment more financially viable for patients and healthcare institutions, reducing the economic burden. Gamma knife technology providers typically undergo rigorous regulatory processes to gain approval for their systems. Clear regulatory pathways can instill confidence in healthcare providers and patients.

Awareness and Education Programs Spearhead the Market in Australia

Gamma knife trends in Australia are taking a turn for the better. An 8.4% CAGR is forecast for the country from 2023 to 2033.

Growing awareness among healthcare providers and patients about the benefits of gamma knife radiosurgery, as well as educational programs conducted by Gamma knife centers, can contribute to its adoption.

Favorable reimbursement policies in Australia can make gamma knife treatment more financially viable for patients and healthcare institutions, reducing the economic burden. Gamma knife technology providers typically undergo rigorous regulatory processes to gain approval for their systems. Clear regulatory pathways can instill confidence in healthcare providers and patients.

Ongoing research and development efforts to improve the precision, safety, and effectiveness of the technology, can attract healthcare providers and patients looking for the latest treatment options. The focus on population health management, including precision medicine, can lead to the identification of patient groups that would benefit most from gamma knife treatment, thus promoting its use.

Health Insurance Reforms Driving the Sales in China

The gamma knife market in China is anticipated to expand at a CAGR of 9.9% through 2033.

The shift toward patient centered care models emphasizes individualized treatment options, and the ability of gamma knife to tailor treatments aligns with this trend. Expansions in health insurance coverage and reimbursement for advanced medical procedures can make gamma knife treatment more accessible to a larger patient population.

The Chinese government has been increasing healthcare spending to improve healthcare accessibility and quality. The increased investment can support the acquisition and operation of advanced medical equipment, including gamma knife systems.

Rising cancer incidence and growing awareness of cancer prevention and treatment options contribute to the demand for advanced cancer treatments, such as gamma knife radiosurgery. The adoption of telemedicine and remote consultations has grown in China, making it easier for patients in remote or underserved areas to access expertise in gamma knife treatment planning and monitoring.

Category-wise Insights

The below table highlights how brain metastases segment is projected to lead the market in terms of disease indication, and is expected to account for a share of 69.2% in 2023.

Based on anatomy, the head segment is expected to account for a share of 88.6% in 2023.

Category Shares (in 2023)
Brain Metastases 69.2%
Head 88.6%

Brain Metastases Segment Claims High Demand for Gamma Knife

Based on disease indication, the brain metastases segment is expected to continue dominating the gamma knife market. The segment is expected to account for a share of 69.2% in 2023.

The rising incidence of cancer, including lung, breast, and melanoma, is leading to a higher number of patients with brain metastases. More patients are living longer, increasing the likelihood of developing brain metastases, as cancer survival rates improve.

Advances in cancer diagnosis and surveillance have resulted in earlier detection of brain metastases. Early detection allows for more timely treatment, making gamma knife radiosurgery a valuable option.

Gamma knife radiosurgery is known for its precision and ability to deliver high doses of radiation to specific areas of the brain while minimizing damage to healthy surrounding tissue, which makes it an attractive treatment option for brain metastases.

The non invasive nature of gamma knife radiosurgery reduces the need for open surgery, which can be risky and have longer recovery times. Patients with brain metastases often prefer non invasive treatments.

Head Segment to Hold High Demand for Gamma Knife

Based on anatomy, the head segment is expected to continue dominating the gamma knife market. The segment is expected to account for a share of 88.6% in 2023.

The increasing incidence of brain tumors, both benign and malignant, is a significant driver of growth in the head segment. Brain tumors may require precise and non invasive treatment, making gamma knife a valuable option.

Gamma knife radiosurgery is used to treat various neurological conditions, including arteriovenous malformations (AVMs), trigeminal neuralgia, pituitary tumors, and acoustic neuromas. The versatility of the technology contributes to the growth of this segment.

Advancements in medical treatments have improved the survival rates of patients with neurological conditions, creating a greater need for treatment and management of these conditions in the head segment.

Favorable reimbursement policies from insurance providers and government healthcare systems can make gamma knife treatment for head related conditions more accessible to patients. The growing body of clinical evidence and medical recommendations supporting the use of gamma knife for various head related conditions instills confidence in the technology among healthcare providers and patients.

Competitive Landscape

The key strategies chosen by large companies include several growth strategies such as technology development, expansion as well and mergers and acquisitions to surge market share, reach and revenue.

  • In 2023, Elekta announced the launch of its new Elekta Esprit gamma knife system. The system features faster treatment planning, improved accuracy, and a more user friendly interface.
  • In the same year, Accuray announced the launch of its new Accuray CyberKnife S7 system. The system features improved image guidance and treatment planning capabilities, as well as a more patient friendly design.
  • In 2022, MASEP announced the launch of its new MASEP gamma knife system. The system is the first gamma knife system to be developed in China.

Report Scope

Attribute Details
Estimated Market Size in 2023 US$ 337.7 million
Projected Market Valuation in 2033 US$ 702.5 million
Value-based CAGR 2023 to 2033 7.6%
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis Value in US$ million
Key Regions Covered North America Latin America Western Europe Eastern Europe South Asia and Pacific East Asia The Middle East & Africa
Key Market Segments Covered Disease Indication Anatomy Region
Key Countries Profiled The United States Canada Brazil Mexico Germany France France Spain Italy Russia Poland Czech Republic Romania India Bangladesh Australia New Zealand China Japan South Korea GCC countries South Africa Israel
Key Companies Profiled
  • Elekta
  • Varian Medical Systems
  • Huiheng Medical, Inc.
  • Akesis, Inc
  • MASEP Medical Science Technology Development (Shenzhen) Co., Ltd.
  • American Radiosurgery Inc.
  • Panacea Medical Technologies Pvt. Ltd.
  • Nordion (Canada) Inc.
  • Accuray Incorporated
  • Hitachi, Ltd.

Segmentation Analysis of the Gamma Knife Market

By Disease Indication:

  • Brain Metastasis
  • Cancer
  • Arteriovenous Malformation
  • Trigeminal Neuralgia
  • Others

By Anatomy:

  • Head
  • Neck
  • Other Body Parts

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia & Pacific
  • East Asia
  • The Middle East & Africa

Frequently Asked Questions

What is the expected worth of the Gamma Knife market in 2023?

The gamma knife market is expected to reach US$ 337.7 million in 2023.

What is the expected CAGR for the Gamma Knife market until 2033?

The market for gamma knife is set to expand by a CAGR of 7.6% by 2033.

How much valuation is projected for the Gamma Knife market in 2033?

The gamma knife market is forecast to reach US$ 702.5 million by 2033.

Which country is likely to be at the pinnacle of the Gamma Knife market?

India is to be the top performing market, with a CAGR of 11.4% through 2033.

Which is the leading disease indication in the Gamma Knife domain?

Brain metastases segment is preferred, and is expected to account for a share of 69.2% in 2033.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Disease Indication

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Disease Indication, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Disease Indication, 2023 to 2033

        5.3.1. Brain Metastasis

        5.3.2. Cancer

        5.3.3. Arteriovenous Malformation

        5.3.4. Trigeminal Neuralgia

        5.3.5. Others

    5.4. Y-o-Y Growth Trend Analysis By Disease Indication, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Disease Indication, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Anatomy

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Anatomy, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Anatomy, 2023 to 2033

        6.3.1. Head

        6.3.2. Neck

        6.3.3. Other Body Parts

    6.4. Y-o-Y Growth Trend Analysis By Anatomy, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Anatomy, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Western Europe

        7.3.4. Eastern Europe

        7.3.5. South Asia and Pacific

        7.3.6. East Asia

        7.3.7. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1. USA

            8.2.1.2. Canada

        8.2.2. By Disease Indication

        8.2.3. By Anatomy

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Disease Indication

        8.3.3. By Anatomy

    8.4. Key Takeaways

9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Disease Indication

        9.2.3. By Anatomy

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Disease Indication

        9.3.3. By Anatomy

    9.4. Key Takeaways

10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. UK

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Western Europe

        10.2.2. By Disease Indication

        10.2.3. By Anatomy

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Disease Indication

        10.3.3. By Anatomy

    10.4. Key Takeaways

11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Poland

            11.2.1.2. Russia

            11.2.1.3. Czech Republic

            11.2.1.4. Romania

            11.2.1.5. Rest of Eastern Europe

        11.2.2. By Disease Indication

        11.2.3. By Anatomy

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Disease Indication

        11.3.3. By Anatomy

    11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Bangladesh

            12.2.1.3. Australia

            12.2.1.4. New Zealand

            12.2.1.5. Rest of South Asia and Pacific

        12.2.2. By Disease Indication

        12.2.3. By Anatomy

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Disease Indication

        12.3.3. By Anatomy

    12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Disease Indication

        13.2.3. By Anatomy

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Disease Indication

        13.3.3. By Anatomy

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Disease Indication

        14.2.3. By Anatomy

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Disease Indication

        14.3.3. By Anatomy

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Disease Indication

            15.1.2.2. By Anatomy

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Disease Indication

            15.2.2.2. By Anatomy

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Disease Indication

            15.3.2.2. By Anatomy

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Disease Indication

            15.4.2.2. By Anatomy

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Disease Indication

            15.5.2.2. By Anatomy

    15.6. UK

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Disease Indication

            15.6.2.2. By Anatomy

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Disease Indication

            15.7.2.2. By Anatomy

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Disease Indication

            15.8.2.2. By Anatomy

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Disease Indication

            15.9.2.2. By Anatomy

    15.10. Poland

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Disease Indication

            15.10.2.2. By Anatomy

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Disease Indication

            15.11.2.2. By Anatomy

    15.12. Czech Republic

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Disease Indication

            15.12.2.2. By Anatomy

    15.13. Romania

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Disease Indication

            15.13.2.2. By Anatomy

    15.14. India

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Disease Indication

            15.14.2.2. By Anatomy

    15.15. Bangladesh

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Disease Indication

            15.15.2.2. By Anatomy

    15.16. Australia

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Disease Indication

            15.16.2.2. By Anatomy

    15.17. New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Disease Indication

            15.17.2.2. By Anatomy

    15.18. China

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2022

            15.18.2.1. By Disease Indication

            15.18.2.2. By Anatomy

    15.19. Japan

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2022

            15.19.2.1. By Disease Indication

            15.19.2.2. By Anatomy

    15.20. South Korea

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2022

            15.20.2.1. By Disease Indication

            15.20.2.2. By Anatomy

    15.21. GCC Countries

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2022

            15.21.2.1. By Disease Indication

            15.21.2.2. By Anatomy

    15.22. South Africa

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2022

            15.22.2.1. By Disease Indication

            15.22.2.2. By Anatomy

    15.23. Israel

        15.23.1. Pricing Analysis

        15.23.2. Market Share Analysis, 2022

            15.23.2.1. By Disease Indication

            15.23.2.2. By Anatomy

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Disease Indication

        16.3.3. By Anatomy

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Elekta

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. Varian Medical Systems

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. Huiheng Medical, Inc.

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. Akesis, Inc

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. MASEP Medical Science Technology Development (Shenzhen) Co., Ltd.

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. American Radiosurgery Inc.

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. Panacea Medical Technologies Pvt. Ltd.

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. Nordion (Canada) Inc.

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. Accuray Incorporated

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. Hitachi, Ltd.

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033

Table 2: Global Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033

Table 3: Global Market Value (US$ Million) Forecast by Anatomy, 2018 to 2033

Table 4: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 5: North America Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033

Table 6: North America Market Value (US$ Million) Forecast by Anatomy, 2018 to 2033

Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 8: Latin America Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033

Table 9: Latin America Market Value (US$ Million) Forecast by Anatomy, 2018 to 2033

Table 10: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 11: Western Europe Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033

Table 12: Western Europe Market Value (US$ Million) Forecast by Anatomy, 2018 to 2033

Table 13: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 14: Eastern Europe Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033

Table 15: Eastern Europe Market Value (US$ Million) Forecast by Anatomy, 2018 to 2033

Table 16: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 17: South Asia and Pacific Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033

Table 18: South Asia and Pacific Market Value (US$ Million) Forecast by Anatomy, 2018 to 2033

Table 19: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 20: East Asia Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033

Table 21: East Asia Market Value (US$ Million) Forecast by Anatomy, 2018 to 2033

Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033

Table 24: Middle East and Africa Market Value (US$ Million) Forecast by Anatomy, 2018 to 2033
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Market Value (US$ Million) by Disease Indication, 2023 to 2033

Figure 2: Global Market Value (US$ Million) by Anatomy, 2023 to 2033

Figure 3: Global Market Value (US$ Million) by Region, 2023 to 2033

Figure 4: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033

Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 7: Global Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033

Figure 8: Global Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033

Figure 9: Global Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033

Figure 10: Global Market Value (US$ Million) Analysis by Anatomy, 2018 to 2033

Figure 11: Global Market Value Share (%) and BPS Analysis by Anatomy, 2023 to 2033

Figure 12: Global Market Y-o-Y Growth (%) Projections by Anatomy, 2023 to 2033

Figure 13: Global Market Attractiveness by Disease Indication, 2023 to 2033

Figure 14: Global Market Attractiveness by Anatomy, 2023 to 2033

Figure 15: Global Market Attractiveness by Region, 2023 to 2033

Figure 16: North America Market Value (US$ Million) by Disease Indication, 2023 to 2033

Figure 17: North America Market Value (US$ Million) by Anatomy, 2023 to 2033

Figure 18: North America Market Value (US$ Million) by Country, 2023 to 2033

Figure 19: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 22: North America Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033

Figure 23: North America Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033

Figure 24: North America Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033

Figure 25: North America Market Value (US$ Million) Analysis by Anatomy, 2018 to 2033

Figure 26: North America Market Value Share (%) and BPS Analysis by Anatomy, 2023 to 2033

Figure 27: North America Market Y-o-Y Growth (%) Projections by Anatomy, 2023 to 2033

Figure 28: North America Market Attractiveness by Disease Indication, 2023 to 2033

Figure 29: North America Market Attractiveness by Anatomy, 2023 to 2033

Figure 30: North America Market Attractiveness by Country, 2023 to 2033

Figure 31: Latin America Market Value (US$ Million) by Disease Indication, 2023 to 2033

Figure 32: Latin America Market Value (US$ Million) by Anatomy, 2023 to 2033

Figure 33: Latin America Market Value (US$ Million) by Country, 2023 to 2033

Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 37: Latin America Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033

Figure 38: Latin America Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033

Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033

Figure 40: Latin America Market Value (US$ Million) Analysis by Anatomy, 2018 to 2033

Figure 41: Latin America Market Value Share (%) and BPS Analysis by Anatomy, 2023 to 2033

Figure 42: Latin America Market Y-o-Y Growth (%) Projections by Anatomy, 2023 to 2033

Figure 43: Latin America Market Attractiveness by Disease Indication, 2023 to 2033

Figure 44: Latin America Market Attractiveness by Anatomy, 2023 to 2033

Figure 45: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 46: Western Europe Market Value (US$ Million) by Disease Indication, 2023 to 2033

Figure 47: Western Europe Market Value (US$ Million) by Anatomy, 2023 to 2033

Figure 48: Western Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 49: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 50: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 51: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 52: Western Europe Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033

Figure 53: Western Europe Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033

Figure 54: Western Europe Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033

Figure 55: Western Europe Market Value (US$ Million) Analysis by Anatomy, 2018 to 2033

Figure 56: Western Europe Market Value Share (%) and BPS Analysis by Anatomy, 2023 to 2033

Figure 57: Western Europe Market Y-o-Y Growth (%) Projections by Anatomy, 2023 to 2033

Figure 58: Western Europe Market Attractiveness by Disease Indication, 2023 to 2033

Figure 59: Western Europe Market Attractiveness by Anatomy, 2023 to 2033

Figure 60: Western Europe Market Attractiveness by Country, 2023 to 2033

Figure 61: Eastern Europe Market Value (US$ Million) by Disease Indication, 2023 to 2033

Figure 62: Eastern Europe Market Value (US$ Million) by Anatomy, 2023 to 2033

Figure 63: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 64: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 65: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 66: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 67: Eastern Europe Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033

Figure 68: Eastern Europe Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033

Figure 69: Eastern Europe Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033

Figure 70: Eastern Europe Market Value (US$ Million) Analysis by Anatomy, 2018 to 2033

Figure 71: Eastern Europe Market Value Share (%) and BPS Analysis by Anatomy, 2023 to 2033

Figure 72: Eastern Europe Market Y-o-Y Growth (%) Projections by Anatomy, 2023 to 2033

Figure 73: Eastern Europe Market Attractiveness by Disease Indication, 2023 to 2033

Figure 74: Eastern Europe Market Attractiveness by Anatomy, 2023 to 2033

Figure 75: Eastern Europe Market Attractiveness by Country, 2023 to 2033

Figure 76: South Asia and Pacific Market Value (US$ Million) by Disease Indication, 2023 to 2033

Figure 77: South Asia and Pacific Market Value (US$ Million) by Anatomy, 2023 to 2033

Figure 78: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033

Figure 79: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 80: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 81: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 82: South Asia and Pacific Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033

Figure 83: South Asia and Pacific Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033

Figure 84: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033

Figure 85: South Asia and Pacific Market Value (US$ Million) Analysis by Anatomy, 2018 to 2033

Figure 86: South Asia and Pacific Market Value Share (%) and BPS Analysis by Anatomy, 2023 to 2033

Figure 87: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Anatomy, 2023 to 2033

Figure 88: South Asia and Pacific Market Attractiveness by Disease Indication, 2023 to 2033

Figure 89: South Asia and Pacific Market Attractiveness by Anatomy, 2023 to 2033

Figure 90: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033

Figure 91: East Asia Market Value (US$ Million) by Disease Indication, 2023 to 2033

Figure 92: East Asia Market Value (US$ Million) by Anatomy, 2023 to 2033

Figure 93: East Asia Market Value (US$ Million) by Country, 2023 to 2033

Figure 94: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 95: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 96: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 97: East Asia Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033

Figure 98: East Asia Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033

Figure 99: East Asia Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033

Figure 100: East Asia Market Value (US$ Million) Analysis by Anatomy, 2018 to 2033

Figure 101: East Asia Market Value Share (%) and BPS Analysis by Anatomy, 2023 to 2033

Figure 102: East Asia Market Y-o-Y Growth (%) Projections by Anatomy, 2023 to 2033

Figure 103: East Asia Market Attractiveness by Disease Indication, 2023 to 2033

Figure 104: East Asia Market Attractiveness by Anatomy, 2023 to 2033

Figure 105: East Asia Market Attractiveness by Country, 2023 to 2033

Figure 106: Middle East and Africa Market Value (US$ Million) by Disease Indication, 2023 to 2033

Figure 107: Middle East and Africa Market Value (US$ Million) by Anatomy, 2023 to 2033

Figure 108: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033

Figure 109: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 110: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 111: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 112: Middle East and Africa Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033

Figure 113: Middle East and Africa Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033

Figure 114: Middle East and Africa Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033

Figure 115: Middle East and Africa Market Value (US$ Million) Analysis by Anatomy, 2018 to 2033

Figure 116: Middle East and Africa Market Value Share (%) and BPS Analysis by Anatomy, 2023 to 2033

Figure 117: Middle East and Africa Market Y-o-Y Growth (%) Projections by Anatomy, 2023 to 2033

Figure 118: Middle East and Africa Market Attractiveness by Disease Indication, 2023 to 2033

Figure 119: Middle East and Africa Market Attractiveness by Anatomy, 2023 to 2033

Figure 120: Middle East and Africa Market Attractiveness by Country, 2023 to 2033

Recommendations

Healthcare

Radiotherapy Device Market

Published : October 2023

Healthcare

Mobile Gamma Cameras Market

Published : September 2023

Healthcare

Gamma Probe Devices Market

Published : February 2023

Healthcare

Ultrasound Devices Market

Published : November 2022

Explore Healthcare Insights

View Reports